ZA976189B - Oral pharmaceutical combinations - Google Patents

Oral pharmaceutical combinations

Info

Publication number
ZA976189B
ZA976189B ZA976189A ZA976189A ZA976189B ZA 976189 B ZA976189 B ZA 976189B ZA 976189 A ZA976189 A ZA 976189A ZA 976189 A ZA976189 A ZA 976189A ZA 976189 B ZA976189 B ZA 976189B
Authority
ZA
South Africa
Prior art keywords
oral pharmaceutical
pharmaceutical combinations
combinations
oral
pharmaceutical
Prior art date
Application number
ZA976189A
Other languages
English (en)
Inventor
Werner Tschollar
Beat Schmid
Uwe Rolf Juergens
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of ZA976189B publication Critical patent/ZA976189B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA976189A 1996-07-12 1997-07-11 Oral pharmaceutical combinations ZA976189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810460 1996-07-12

Publications (1)

Publication Number Publication Date
ZA976189B true ZA976189B (en) 1999-01-11

Family

ID=8225649

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976189A ZA976189B (en) 1996-07-12 1997-07-11 Oral pharmaceutical combinations

Country Status (3)

Country Link
AU (1) AU3444297A (xx)
WO (1) WO1998002182A1 (xx)
ZA (1) ZA976189B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267945B1 (en) 1998-12-18 2001-07-31 Neuromed Technologies, Inc. Farnesol-related calcium channel blockers
WO2001019346A1 (en) * 1999-09-14 2001-03-22 Copley Pharmaceutical, Inc. Delayed release nabumetone formulation
JP3553562B2 (ja) * 2000-08-25 2004-08-11 興和株式会社 イブプロフェンカプセル充填液及びカプセル製剤
CA2483105C (en) * 2002-05-13 2011-05-10 Arexis Ab Autoimmune conditions and nadph oxidase defects
DE10229472A1 (de) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Kompaktierter Milchsäurementhylester
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP2586470B1 (en) 2008-02-14 2020-07-15 KCI Licensing, Inc. Devices for treatment of damaged tissue
CN103998028B (zh) * 2011-10-20 2017-12-08 卓莫赛尔公司 用于减小或消除苦味的化合物、组合物和方法
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020013781A2 (en) 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020033567A1 (en) * 2018-08-07 2020-02-13 University Of Florida Research Foundation Methods and compositions for substituted arylcycloheptane analogs
CN113491679A (zh) * 2021-03-18 2021-10-12 云南民族大学 植醇在制备抗偏头痛药物中的应用
CN114959012B (zh) * 2022-05-30 2023-04-07 北京医院 用于检测肌腱损伤的产品

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608226A1 (de) * 1976-02-28 1977-09-08 Haarmann & Reimer Gmbh Mittel mit physiologischer kuehlwirkung
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
EP0093520B1 (en) * 1982-04-27 1986-10-15 Noristan Limited Pharmaceutical compositions and preparation thereof
US4929446A (en) * 1988-04-19 1990-05-29 American Cyanamid Company Unit dosage form
EP0421825A1 (en) * 1989-08-11 1991-04-10 Kadem Farmaseutiese Produktie B.K. Paracetamol solutions
GB9110929D0 (en) * 1991-05-21 1991-07-10 Idb Holding Spa Ursane derivatives,their preparation and pharmaceutical formulations thereof
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
RO112991B1 (ro) * 1992-09-18 1998-03-30 Yamanouchi Pharma Co Ltd Preparat tip hidrogel, cu eliberare sustinuta
AU5134893A (en) * 1992-10-09 1994-05-09 Procter & Gamble Company, The Anaesthetic compositions
JPH08509725A (ja) * 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
AU1655595A (en) * 1994-04-29 1995-11-09 Mcneil-Ppc, Inc. Solid pharmaceutical dosage form containing flavored film coating

Also Published As

Publication number Publication date
WO1998002182A1 (en) 1998-01-22
AU3444297A (en) 1998-02-09

Similar Documents

Publication Publication Date Title
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
GB9613470D0 (en) Small solid oral dosage form
EP1020193A4 (en) ORAL PREPARATION
HUP9901674A3 (en) New pharmaceutical combination
GB9602080D0 (en) Pharmaceutical compounds
EG24118A (en) Pharmaceutical compositions
EP0943327A4 (en) DRUG
GB9715490D0 (en) Pharmaceutical preparation
GB9609976D0 (en) Pharmaceutical compounds
ZA976189B (en) Oral pharmaceutical combinations
EP0907644A4 (en) PHARMACEUTICAL PREPARATION
GB9621789D0 (en) Pharmaceutical compounds
EP0923564A4 (en) PHARMACEUTICAL COMPOUNDS
GB9606429D0 (en) Pharmaceutical compositions
ZA979329B (en) Pharmaceutical compounds
GB9623962D0 (en) Pharmaceutical composition
GB9626151D0 (en) Pharmaceutical compounds
GB9618964D0 (en) Oral composition
ZA974125B (en) Oral pharmaceutical compositions
ZA976144B (en) Oral pharmaceutical compositions
GB9617896D0 (en) Pharmaceutical preparation
GB9604108D0 (en) Pharmaceutical preparation
GB9606019D0 (en) Pharmaceutical preparation
GB9607890D0 (en) Pharmaceutical preparation
GB9617894D0 (en) Pharmaceutical preparation